An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis

Recruiting

Phase 2

ORKA-001An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis

Sponsor:

Oruka Therapeutics, Inc.

Code:

NCT07449702

Conditions

Plaque Psoriasis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ORKA-001

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-02. This information was provided to ClinicalTrials.gov by Oruka Therapeutics, Inc. on 2026-04-01.